Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 3/2012

01.09.2012 | Stress Incontinence and Pelvic Prolapse (RR Dmochowski, Section Editor)

Mesh for Anterior Pelvic Organ Prolapse: Where Do We Go Now?

verfasst von: Ahmed El-Zawahry, Michelle E. Koski, Eric Rovner

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Pelvic organ prolapse (POP) repair using native tissue has a significant risk of failure, especially for anterior compartment repair. Surgical techniques using a variety of mesh grafts and approaches have been developed to decrease the risk of recurrence and improve overall outcomes. Some, but not all, studies have demonstrated that synthetic mesh grafts and mesh kits improve objective outcomes. However, reports of complications with the use of synthetic mesh grafts and mesh kits have been emerging. Such reports have stirred the interests of physicians, medical societies, the media, and regulatory agencies such as the US Food and Drug Administration (FDA), which in July 2011 issued a Safety Communication updating a 2008 statement warning about synthetic mesh and mesh kit complications associated with POP repair. This article discusses current and future directions using synthetic mesh for anterior compartment POP repair in the context of the recent FDA communication.
Literatur
1.
Birch C, Fynes MM. The role of synthetic and biological prostheses in reconstructive pelvic floor surgery. Curr Opin Obstet Gynecol. 2002;14:527–35.PubMedCrossRef
2.
Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501–6.PubMedCrossRef
3.
Sokol AI, Iglesia CB, Kudish BI, et al. One-year objective and functional outcomes of a randomized clinical trial of vaginal mesh for prolapse. Am J Obstet Gynecol. 2012;206(86):e81–9.
4.
Whiteside JL, Weber AM, Meyn LA, Walters MD. Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol. 2004;191:1533–8.PubMedCrossRef
5.
Chen CC, Ridgeway B, Paraiso MF. Biologic grafts and synthetic meshes in pelvic reconstructive surgery. Clin Obstet Gynecol. 2007;50:383–411.PubMedCrossRef
6.
Scott NW, Mccormack K, Graham P, et al. Open mesh versus non-mesh for repair of femoral and inguinal hernia. Cochrane Database Syst Rev. 2002;CD002197.
7.
Nygaard IE, Mccreery R, Brubaker L, et al. Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol. 2004;104:805–23.PubMedCrossRef
8.
Julian TM. The efficacy of marlex mesh in the repair of severe, recurrent vaginal prolapse of the anterior midvaginal wall. Am J Obstet Gynecol. 1996;175:1472–5.PubMedCrossRef
9.
10.
De Tayrac R, Gervaise A, Chauveaud A, Fernandez H. Tension-free polypropylene mesh for vaginal repair of anterior vaginal wall prolapse. J Reprod Med. 2005;50:75–80.PubMed
11.
Migliari R, Usai E. Treatment results using a mixed fiber mesh in patients with grade iv cystocele. J Urol. 1999;161:1255–8.PubMedCrossRef
12.
Migliari R, De Angelis M, Madeddu G, Verdacchi T. Tension-free vaginal mesh repair for anterior vaginal wall prolapse. Eur Urol. 2000;38:151–5.PubMedCrossRef
13.
Milani R, Salvatore S, Soligo M, et al. Functional and anatomical outcome of anterior and posterior vaginal prolapse repair with prolene mesh. Bjog. 2005;112:107–11.PubMedCrossRef
14.
Culligan PJ, Blackwell L, Goldsmith LJ, et al. A randomized controlled trial comparing fascia lata and synthetic mesh for sacral colpopexy. Obstet Gynecol. 2005;106:29–37.PubMedCrossRef
15.
•• Moore RD, Miklos JR. Vaginal mesh kits for pelvic organ prolapse, friend or foe: a comprehensive review. Sci World J. 2009;9:163–89. This is a good review of different vaginal mesh kits used in the market.CrossRef
16.
Jia X, Glazener C, Mowatt G, et al. Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systematic review and meta-analysis. Bjog. 2008;115:1350–61.PubMedCrossRef
17.
• Murphy M, Holzberg A, Van Raalte H, et al. Time to rethink: an evidence-based response from pelvic surgeons to the FDA safety communication: “Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse”. Int Urogynecol J. 2012;23:5–9. This is an excellent article in response to the FDA updates on vaginal mesh for prolapse.PubMedCrossRef
18.
Davila GW, Drutz H, Deprest J. Clinical implications of the biology of grafts: conclusions of the 2005 iuga grafts roundtable. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17 Suppl 1:S51–5.PubMed
19.
Brubaker L, Bump RC, Fynes MM, ABrams P, Cardozo L, Koury S, Wein A, et al. Surgery for pelvic organ prolapse. In: Incontinence. Paris: Health Publication Ltd; 2005. p. 1371–402.
20.
Amid PK. Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia. 1997;1:15–21.CrossRef
21.
White RA. The effect of porosity and biomaterial on the healing and long-term mechanical properties of vascular prostheses. ASAIO Trans. 1988;34:95–100.PubMedCrossRef
22.
Bobyn JD, Wilson GJ, Macgregor DC, et al. Effect of pore size on the peel strength of attachment of fibrous tissue to porous-surfaced implants. J Biomed Mater Res. 1982;16:571–84.PubMedCrossRef
23.
•• Jia X, Glazener C, Mowatt G, et al. Systematic review of the efficacy and safety of using mesh in surgery for uterine or vaginal vault prolapse. Int Urogynecol J. 2010;21:1413–31. This is a good meta-analysis on different studies discussing the use of mesh for vaginal surgery.PubMedCrossRef
24.
Groutz A, Chaikin DC, Theusen E, Blaivas JG. Use of cadaveric solvent-dehydrated fascia lata for cystocele repair–preliminary results. Urology. 2001;58:179–83.PubMedCrossRef
25.
Kobashi KC, Leach GE, Chon J, Govier FE. Continued multicenter followup of cadaveric prolapse repair with sling. J Urol. 2002;168:2063–8.PubMedCrossRef
26.
Frederick RW, Leach GE. Cadaveric prolapse repair with sling: intermediate outcomes with 6 months to 5 years of followup. J Urol. 2005;173:1229–33.PubMedCrossRef
27.
Gandhi S, Goldberg RP, Kwon C, et al. A prospective randomized trial using solvent dehydrated fascia lata for the prevention of recurrent anterior vaginal wall prolapse. Am J Obstet Gynecol. 2005;192:1649–54.PubMedCrossRef
28.
Chung SY, Franks M, Smith CP, et al. Technique of combined pubovaginal sling and cystocele repair using a single piece of cadaveric dermal graft. Urology. 2002;59:538–41.PubMedCrossRef
29.
Salomon LJ, Detchev R, Barranger E, et al. Treatment of anterior vaginal wall prolapse with porcine skin collagen implant by the transobturator route: preliminary results. Eur Urol. 2004;45:219–25.PubMedCrossRef
30.
Leboeuf L, Miles RA, Kim SS, Gousse AE. Grade 4 cystocele repair using four-defect repair and porcine xenograft acellular matrix (pelvicol): outcome measures using seapi. Urology. 2004;64:282–6.PubMedCrossRef
31.
Clemons JL, Myers DL, Aguilar VC, Arya LA. Vaginal paravaginal repair with an alloderm graft. Am J Obstet Gynecol. 2003;189:1612–8. discussion 1618-1619.PubMedCrossRef
32.
Wheeler 2nd TL, Richter HE, Duke AG, et al. Outcomes with porcine graft placement in the anterior vaginal compartment in patients who undergo high vaginal uterosacral suspension and cystocele repair. Am J Obstet Gynecol. 2006;194:1486–91.PubMedCrossRef
33.
Weber AM, Walters MD, Piedmonte MR, Ballard LA. Anterior colporrhaphy: a randomized trial of three surgical techniques. Am J Obstet Gynecol. 2001;185:1299–304. discussion 1304-1296.PubMedCrossRef
34.
Sand PK, Koduri S, Lobel RW, et al. Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles. Am J Obstet Gynecol. 2001;184:1357–62. discussion 1362-1354.PubMedCrossRef
35.
Flood CG, Drutz HP, Waja L. Anterior colporrhaphy reinforced with marlex mesh for the treatment of cystoceles. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9:200–4.PubMedCrossRef
36.
Cervigni M, Natale F, La Penna C, et al. Transvaginal cystocele repair with polypropylene mesh using a tension-free technique. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:489–96.PubMedCrossRef
37.
Fatton B, Amblard J, Debodinance P, et al. Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (prolift technique)–a case series multicentric study. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:743–52.PubMedCrossRef
38.
Jacquetin B, Cosson M. Complications of vaginal mesh: our experience. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:893–6.PubMedCrossRef
39.
Boyles SH, Mccrery R. Dyspareunia and mesh erosion after vaginal mesh placement with a kit procedure. Obstet Gynecol. 2008;111:969–75.PubMedCrossRef
40.
Araco F, Gravante G, Sorge R, et al. Risk evaluation of smoking and age on the occurrence of postoperative erosions after transvaginal mesh repair for pelvic organ prolapses. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:473–9.PubMedCrossRef
41.
Ostergard DR. Polypropylene vaginal mesh grafts in gynecology. Obstet Gynecol. 2010;116:962–6.PubMedCrossRef
42.
Dwyer PL, O’reilly BA. Transvaginal repair of anterior and posterior compartment prolapse with atrium polypropylene mesh. Bjog. 2004;111:831–6.PubMedCrossRef
43.
Kuuva N, Nilsson CG. A nationwide analysis of complications associated with the tension-free vaginal tape (tvt) procedure. Acta Obstet Gynecol Scand. 2002;81:72–7.PubMedCrossRef
44.
Klinge U, Klosterhalfen B, Muller M, et al. Shrinking of polypropylene mesh in vivo: an experimental study in dogs. Eur J Surg. 1998;164:965–9.PubMedCrossRef
45.
Cosson M, Debodinance P, Boukerrou M, et al. Mechanical properties of synthetic implants used in the repair of prolapse and urinary incontinence in women: which is the ideal material? Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:169–78. discussion 178.PubMedCrossRef
46.
• Gauruder-Burmester A, Koutouzidou P, Tunn R. Effect of vaginal polypropylene mesh implants on sexual function. Eur J Obstet Gynecol Reprod Biol. 2009;142:76–80. This article discusses implications of vaginal mesh on sexual function.PubMedCrossRef
47.
Dietz HP, Erdmann M, Shek KL. Mesh contraction: myth or reality? Am J Obstet Gynecol. 2011;204(173):e171–4.
48.
Margulies RU, Lewicky-Gaupp C, Fenner DE, et al. Complications requiring reoperation following vaginal mesh kit procedures for prolapse. Am J Obstet Gynecol. 2008;199(678):e671–4.
49.
Gangam N, Kanee A. Retroperitoneal hemorrhage after a vaginal mesh prolapse procedure. Obstet Gynecol. 2007;110:463–4.PubMedCrossRef
50.
Touboul C, Nizard J, Fauconnier A, Bader G. Major venous hemorrhagic complication during transvaginal cystocele repair using the transobturator approach. Obstet Gynecol. 2008;111:492–5.PubMedCrossRef
51.
Mokrzycki ML, Hampton BS. Pelvic arterial embolization in the setting of acute hemorrhage as a result of the anterior prolift procedure. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:813–5.PubMedCrossRef
52.
• Altman D, Vayrynen T, Engh ME, et al. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011;364:1826–36. This is an RCT discussing the results of vaginal mesh used for POP.PubMedCrossRef
53.
Silva WA, Karram MM. Scientific basis for use of grafts during vaginal reconstructive procedures. Curr Opin Obstet Gynecol. 2005;17:519–29.PubMedCrossRef
54.
• Tijdink MM, Vierhout ME, Heesakkers JP, Withagen MI. Surgical management of mesh-related complications after prior pelvic floor reconstructive surgery with mesh. Int Urogynecol J. 2011;22:1395–404. This is a good article discussing the outcomes of treament of mesh complications.PubMedCrossRef
55.
• Marcus-Braun N, Von Theobald P. Mesh removal following transvaginal mesh placement: a case series of 104 operations. Int Urogynecol J. 2010;21:423–30. This is a good study discussing results of mesh removal.PubMedCrossRef
56.
Nieminen K, Hiltunen R, Heiskanen E, et al. Symptom resolution and sexual function after anterior vaginal wall repair with or without polypropylene mesh. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1611–6.PubMedCrossRef
57.
Lowman JK, Jones LA, Woodman PJ, Hale DS. Does the prolift system cause dyspareunia? Am J Obstet Gynecol. 2008;199(707):e701–6.
58.
• Milani AL, Withagen MI, The HS, et al. Sexual function following trocar-guided mesh or vaginal native tissue repair in recurrent prolapse: a randomized controlled trial. J Sex Med. 2011;8:2944–53. This is an RCT discussing effects of vaginal surgery on sexual function.PubMedCrossRef
59.
Nguyen JN, Burchette RJ. Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol. 2008;111:891–8.PubMedCrossRef
60.
Sivaslioglu AA, Unlubilgin E, Dolen I. A randomized comparison of polypropylene mesh surgery with site-specific surgery in the treatment of cystocoele. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:467–71.PubMedCrossRef
61.
The Food and Drug Administration: FDA: surgical placement of mesh to repair pelvic organ prolapse poses risks. 2011.
62.
The Food and Drug Administration. FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. 2008.
63.
Drutz HP, Alarab M. Pelvic organ prolapse: demographics and future growth prospects. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17 Suppl 1:S6–9.PubMed
64.
Meier B. F.D.A. Orders surgical mesh makers to study risks: the New York Times; 2012.
65.
The American Urologic Association (AUA) response to the FDA mesh statement. 2012.
66.
The Society of Urodynamics, female pelvic medicine and Urogenital reconstruction (SUFU) response to the FDA mesh statement, 2011, 2012.
67.
The American Urogynecologic Society (AUGS) response to the FDA mesh statement, 2011, 2012.
68.
The American Congress of Obstetricians and Gynecologists (ACOG) response to the FDA mesh statement. 2012.
69.
The Society of Gynecologic Surgeons (SGS) response to the FDA mesh statement. 2011.
70.
• Mucowski SJ, Jurnalov C, Phelps JY. Use of vaginal mesh in the face of recent FDA warnings and litigation. Am J Obstet Gynecol. 2010;203(103):e101–4. This is a discussion of the litigation associated with the current FDA updates on mesh use.
71.
De Ridder D. Should we use meshes in the management of vaginal prolapse? Curr Opin Urol. 2008;18:377–82.PubMedCrossRef
72.
Bako A, Dhar R. Review of synthetic mesh-related complications in pelvic floor reconstructive surgery. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:103–11.PubMedCrossRef
73.
Takacs P, Zhang Y, Jaramillo S, et al. The effects of estrogen, progesterone and polypropylene mesh on vaginal smooth muscle cell proliferation. J Smooth Muscle Res. 2010;46:9–15.PubMedCrossRef
74.
Haylen B, Sand P, Swift SE, et al. Trasvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns- positive reactions are possible. Int Urogynecol J. 2011.
75.
The US Food and Drug Administration (FDA): Premarket notification (510 k), 2009, 2011.
76.
The US Food and Drug Administration (FDA): Urogynecologic surgical mesh implants, 2011, 2012.
77.
Menefee SA, Dyer KY, Lukacz ES, et al. Colporrhaphy compared with mesh or graft-reinforced vaginal paravaginal repair for anterior vaginal wall prolapse: a randomized controlled trial. Obstet Gynecol. 2011.
78.
• Vollebregt A, Fischer K, Gietelink D, Van Der Vaart CH. Primary surgical repair of anterior vaginal prolapse: a randomised trial comparing anatomical and functional outcome between anterior colporrhaphy and trocar-guided transobturator anterior mesh. Bjog. 2011;118:1518–27. This is an RCT discussing anatomic and functional outcomes of traditional compared with mesh repair of anterior POP.PubMedCrossRef
79.
Lo TS, Ashok K. Combined anterior trans-obturator mesh and sacrospinous ligament fixation in women with severe prolapse–a case series of 30 months follow-up. Int Urogynecol J. 2011;22:299–306.PubMedCrossRef
80.
Eboue C, Marcus-Braun N, Von Theobald P. Cystocele repair by transobturator four arms mesh: monocentric experience of first 123 patients. Int Urogynecol J. 2010;21:85–93.PubMedCrossRef
81.
• Nieminen K, Hiltunen R, Takala T, et al. Outcomes after anterior vaginal wall repair with mesh: a randomized, controlled trial with a 3 year follow-up. Am J Obstet Gynecol. 2010;203(235):e231–8. This is an RCT discussing outcomes of using mesh for anterior POP repair.
Metadaten
Titel
Mesh for Anterior Pelvic Organ Prolapse: Where Do We Go Now?
verfasst von
Ahmed El-Zawahry
Michelle E. Koski
Eric Rovner
Publikationsdatum
01.09.2012
Verlag
Current Science Inc.
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 3/2012
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-012-0142-y

Weitere Artikel der Ausgabe 3/2012

Current Bladder Dysfunction Reports 3/2012 Zur Ausgabe

Voiding Dysfunction Evaluation (JT Anger, Section Editor)

Evaluation of Postprostatectomy Incontinence: Determining Candidacy for the Transobturator Sling

Voiding Dysfunction Evaluation (JT Anger, Section Editor)

Evaluation of Urinary Retention in Women: Pelvic Floor Dysfunction or Primary Bladder Neck Obstruction

Stress Incontinence and Pelvic Prolapse (RR Dmochowski, Section Editor)

Patient Safety and Surgical Intervention for Urinary Incontinence and Pelvic Organ Prolapse

Voiding Dysfunction Evaluation (JT Anger, Section Editor)

Psychogenic Urinary Dysfunction in Children and Adults

Invited Commentary

Transobturator Mid-Urethral Slings in Current Clinical Practice

Voiding Dysfunction Evaluation (JT Anger, Section Editor)

Neurological Work-Up for Urge Urinary Incontinence: When and in Whom?

Neu im Fachgebiet Urologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise